RYVAX | VENAX | RYVAX / VENAX | |
Total Expense Ratio | 1.63 | 0.09 | 1,811% |
Annual Report Gross Expense Ratio | 1.68 | 0.09 | 1,867% |
Fund Existence | 27 years | 21 years | - |
Gain YTD | -9.984 | 2.971 | -336% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 100000 | 3% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.15M | 9B | 0% |
Annual Yield % from dividends | 0.00 | 3.07 | - |
Returns for 1 year | -7.28 | 5.25 | -139% |
Returns for 3 years | 3.02 | 10.65 | 28% |
Returns for 5 years | 98.28 | 190.75 | 52% |
Returns for 10 years | -57.45 | 40.39 | -142% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FCEF | 22.84 | N/A | N/A |
First Trust Income Opportunity ETF | |||
MAYP | 30.11 | N/A | N/A |
PGIM S&P 500 Buffer 12 ETF - May | |||
KNO | 50.79 | -0.13 | -0.25% |
AXS Knowledge Leaders ETF | |||
VSDA | 53.83 | -0.43 | -0.80% |
VictoryShares Dividend Accelerator ETF | |||
BMEZ | 14.23 | -0.14 | -0.97% |
BlackRock Health Sciences Term Trust |